Cochlear Named #1 Most Trustworthy Healthcare Company In The World For 2026
Cochlear Named #1 Most Trustworthy Healthcare Company In The World For 2026
PR Newswire
LONE TREE, Colo., Oct. 14, 2026
Newsweek's World's Most Trustworthy Companies 2026 Ranks Cochlear as Top Healthcare & Life Sciences Company
LONE TREE, Colo., Oct. 14, 2026 /PRNewswire/ -- Cochlear, the global leader in implantable hearing solutions, is proud to announce that it has been ranked No. 1 in the Health Care & Life Sciences industry by Newsweek in its World's Most Trustworthy Companies 2026 rankings. This marks the second time in three years that Cochlear has earned this prestigious recognition, reinforcing Cochlear's commitment to excellence, innovation, and a recipient first mindset.
The Newsweek ranking was conducted independently in collaboration with global data research firm Statista and evaluated companies on the trust they inspire among customers, investors, and employees. The 2026 edition is based on approximately 200,000 company evaluations from more than 65,000 participants across 20 countries, complemented by an analysis of over 320,000 media mentions, providing a comprehensive global view of organizations distinguished by strong reputations, resilience, and lasting stakeholder trust.
"At Cochlear, our recipients and candidates are at the heart of everything we do. This recognition from Newsweek reflects the dedication of every person across our organization who works tirelessly to support people with hearing loss throughout their entire hearing journey," said Dig Howitt, Chief Executive Officer & President, Cochlear.
"It also reflects our longstanding commitment to earning the trust of those we serve through the quality, reliability, and innovation of our hearing solutions. Every day, we work to provide the best possible outcomes and technology that recipients and professionals can rely on for a lifetime of hearing outcomes. This accolade highlights the dedication to our mission to help people hear and be heard."
About Cochlear Limited (ASX: COH)
People have always been Cochlear's inspiration, ever since Professor Graeme Clark set out to create the first multi-channel cochlear implant after seeing his father struggle with hearing loss. Since 1981, Cochlear has helped more than 800,000 people of all ages in more than 180 countries to hear. As the global leader in implantable hearing solutions, Cochlear connects people with life's opportunities, and welcomes them to the world's largest hearing implant community.
Cochlear has a global workforce of more than 5,500 people with a passion for progress, who strive to meet the needs of people living with hearing loss. The company continually innovates to anticipate future needs, investing more than A$3 billion to date in research and development to push the boundaries of technology and help more people hear.
SOURCE Cochlear North America
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy for the Long-Term While They’re Still Undervalued
6 ETFs To Diversify Away From AI
Are TIPS ETFs the Best Way to Fight Inflation?
What’s Ahead for Stocks This Quarter—and Where to Invest
United States